Company profile
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Privately held: no public share price (Not itself listed; a principal subsidiary of Sino Biopharmaceutical Limited. Parent: Sino Biopharmaceutical Limited (HKEX 1177). [resolved 2026-08-05 by resolve-null-is-public; source: https://en.wikipedia.org/wiki/Sino_Biopharmaceutical_Limited]) · China
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | EGFRSmall molecule | Non-Small Cell Lung Cancer |
Upcoming events
Research
Sign in to access ResearchUnlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Sign in to access ResearchUnlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.